This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by O’Malley, B. W. Search for Related Content PubMed PubMed Citation Articles by O’Malley, B. W.

Coregulators: From Whence Came These "Master Genes"

Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030

Address all correspondence and requests for reprints to: B. W. O’Malley, Baylor College of Medicine, Department of Cell Biology, 1 Baylor Plaza, Houston, Texas 77030. E-mail: berto{at}bcm.tmc.edu.

IT IS NOW OVER a decade since the first nuclear receptor (NR) coactivator, steroid receptor coactivator 1 (SRC-1), was cloned and discovered to be a new type of transcription factor that does not bind DNA, but rather, binds directly or indirectly to NRs to mediate their transcriptional potency. The NR coactivators belong to a class of molecules now termed "coregulators." Employing an operational definition, we define coactivators as molecules that enhance transcription, and corepressors as molecules that repress transcription. Current evidence indicates that this operational definition can be modified by gene, cell, and signaling context for any one coregulator. Our current understanding is that NRs and other DNA-binding transcription factors (TFs) search out the target genes to be regulated by binding to specific DNA sequences (or other TFs at such sequences) termed "TF-response elements" (1 ); the second job of NRs is to recruit the coregulators that perform all of the subsequent reactions needed to induce or repress expression of genes. Initially, we believed that coactivators were simply adapters that stabilized the general transcription machinery at the TATA box. This explanation proved to be incorrect. Over the past decade, the mechanistic importance of coregulators has expanded logarithmically, and we now realize that they perform virtually all of the reactions needed for control of enhancer-dependent gene expression. In this minireview, I will emphasize the history of coactivators, but corepressors are equally important for gene regulation.

NURSA Molecule Pages Link:

Nuclear Receptors:   RARα  |  LXRβ  |  LXRα  |  ERα

Coregulators:   P/CAF  |  CBP  |  SRC-1  |  ASC-2  |  NCOR  |  SMRT

Ligands:   T0901317

This article has been cited by other articles:

				S. Wang, Y. Yuan, L. Liao, S.-Q. Kuang, J. C.-Y. Tien, B. W. O'Malley, and J. Xu Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation PNAS, January 6, 2009; 106(1): 151 - 156. [Abstract] [Full Text] [PDF]

				S. D. Conzen Minireview: Nuclear Receptors and Breast Cancer Mol. Endocrinol., October 1, 2008; 22(10): 2215 - 2228. [Abstract] [Full Text] [PDF]

				H.-J. van den Ham and R. J. de Boer From the two-dimensional Th1 and Th2 phenotypes to high-dimensional models for gene regulation Int. Immunol., October 1, 2008; 20(10): 1269 - 1277. [Abstract] [Full Text] [PDF]

				C. Dimple, S. S. Nair, R. Rajhans, P. R. Pitcheswara, J. Liu, S. Balasenthil, X.-F. Le, M. E. Burow, N. Auersperg, R. R. Tekmal, et al. Role of PELP1/MNAR Signaling in Ovarian Tumorigenesis Cancer Res., June 15, 2008; 68(12): 4902 - 4909. [Abstract] [Full Text] [PDF]

				J. K. Nagpal, S. Nair, D. Chakravarty, R. Rajhans, S. Pothana, D. W. Brann, R. R. Tekmal, and R. K. Vadlamudi Growth Factor Regulation of Estrogen Receptor Coregulator PELP1 Functions via Protein Kinase A Pathway Mol. Cancer Res., May 1, 2008; 6(5): 851 - 861. [Abstract] [Full Text] [PDF]

				A. Biserni, F. Giannessi, A. F. Sciarroni, F. M. Milazzo, A. Maggi, and P. Ciana In Vivo Imaging Reveals Selective Peroxisome Proliferator Activated Receptor Modulator Activity of the Synthetic Ligand 3-(1-(4-Chlorobenzyl)-3-t-butylthio-5-isopropylindol-2-yl)-2,2-dimethylpropanoic acid (MK-886) Mol. Pharmacol., May 1, 2008; 73(5): 1434 - 1443. [Abstract] [Full Text] [PDF]

				Q. Li, M.-J. Chu, and J. Xu Tissue- and Nuclear Receptor-Specific Function of the C-Terminal LXXLL Motif of Coactivator NCoA6/AIB3 in Mice Mol. Cell. Biol., December 1, 2007; 27(23): 8073 - 8086. [Abstract] [Full Text] [PDF]

				D. Stygar, B. Masironi, H. Eriksson, and L. Sahlin Studies on estrogen receptor (ER) {alpha} and {beta} responses on gene regulation in peripheral blood leukocytes in vivo using selective ER agonists J. Endocrinol., July 1, 2007; 194(1): 101 - 119. [Abstract] [Full Text] [PDF]